To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
ImageBiopsy Lab (IB Lab) is a startup based in Vienna dedicated to research on the prediction and assessment of bone diseases. As first use case IB Lab has developed a diagnostic decision support system for osteoarthritis (OA), the most common joint disease worldwide. The IB Lab analyzer software analyzes the severity of OA and the overall health of the bone in a standardized and objective manner. This enables more precisely targeted therapies, cost reduction and better quality of life for patients.
The developed method is based on image recognition algorithms, which works with machine/deep learning on conventional xrays. IB LAB is becoming the one stop shop for bone disease expertise for software assisted diagnostics.
IB Lab’s mission is to enhance patients diagnostic experience and go beyond the current standard of care. Currently, 70 million people suffer from OA in Europe alone. By 2040, this number is predicted to exceed 100 million. Diagnoses are often too late, subjective and might lag details due to time pressure. This demands a solution – now. IB Lab uses state-of-the-art computer-vision and artificial intelligence technology to efficiently solve these problems.
- 1Intas Biopharmaceuticals Ltd.
- 2LPT - Laboratory of Pharmacology and Toxicology GmbH & Co. KG
- 3Ranbaxy Laboratories Ltd.
- 4Life Technologies Corporation
- 5Scientis Pharma SA
- 6MEDICE Arzneimittel Pütter GmbH & Co. KG
- 7Sanofi-Aventis Deutschland GmbH
- 8TranScrip Partners
- 9BIOTON S.A.
- 10Abbott GmbH & Co. KG